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Abstract: Abstract
Background
The community pharmacy Medicines Use Review (MUR)service in England has been
identified as a way of providing support with medication to recently discharged
patients; however initial uptake of post-discharge Medicines Use Reviews has been
low.
Objective
To identify barriers to recruitment into a randomised controlled feasibility study of a
hospital referral system to older patients' regular community pharmacists.
Method
Ward pharmacists at Southport District General Hospital identified patients aged over
65 to be approached by a researcher to assess eligibility and discuss involvement in
the trial.  Participants were randomised to referral for a post discharge MUR with their
regular community pharmacist, or to standard discharge care.   Reasons for patients
not participating were collected.
Results
Over a 9-month period 337 potential participants were identified by ward pharmacists.
Of these, 132 were eligible and 60 were recruited.
Barriers to recruitment included competing priorities among ward pharmacists, and
national restrictions placed on MURs e.g. housebound patients and those requiring
carer support with medication.  Lack of expected benefit resulted in a high proportion of
patient refusals.
Conclusions
The current provisions for post discharge MURs exclude many older people from
participation, including those possibly in greatest need.
Unfamiliarity with the role of the pharmacist in transitional care may have affected
patients' perceived 'cost-benefit' of taking part in this study.
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Impact of Findings on Clinical Pharmacy Practice
*Engaging older patients in the hospital setting with the concept of a post discharge
Medicines Use Review in community pharmacy is challenging.
*Further support for hospital teams to identify and refer suitable patients for post
discharge Medicines Use Reviews is necessary.
*The current provisions for post discharge medicines use reviews in England appear to
cater poorly for patients who are housebound and those who rely on others to support
them with their medicines at home.
Response to Reviewers: Reviewer 1: Comments and Responses
1.In the abstract and on various other occasions throughout the manuscript, the
participants are referred to as the ‘elderly’. I would advise that this terminology be
replaced with ‘older adults’ or ‘older people’, which would be regarded as more
appropriate terms to use when referring to this population. Done
2.In Figure 1, please change ‘10682 Medical Patients’ to ‘10682 medical patients’ and
‘337 Patients’ to ‘337 patients’, (lowercase), in keeping with the word formatting in the
other boxes within the same figure. Done
3.Line 68: ‘Feedback from ward pharmacists via a focus group…’ I would advise that
you add (n=x) or similar, to indicate how many ward pharmacists provided feedback in
the focus group. Done (n=7)
4.Whilst this article predominantly focusses on recruitment being problematic due to it
being a study attempting to recruit older adults, an important finding described in this
research report was that, overall, the pharmacists only referred 3.2% of all patients
admitted, which is a significantly lower proportion than one would expect given the
wider patient population admitted to hospitals. As such, this clearly represented a
major barrier to the recruitment process. As the author(s) states that recruitment of
participants to the study was ‘often forgotten about’ by ward pharmacists (line 70), it is
perhaps unclear to the reader what steps (if any) were taken to ensure that
pharmacists were aware of their role in the recruitment process. This point is also
pertinent as the author(s) also report that of the 337 patients referred to the researcher
by the pharmacists, 105 were ineligible for inclusion as they did not meet the specified
study inclusion criteria. As this represents nearly one third of all those who were
referred, this would lead this reviewer to assume that the ward pharmacists involved in
recruitment were not aware of the study’s inclusion/exclusion criteria (as suggested in
lines 35-36). To address this issue, I think this article would benefit from a comment in
the discussion section to clarify exactly how and to what extent the pharmacists
involved in the recruitment were informed of the recruitment process.
The following comment has now been inserted into the discussion: The low referral
rate was despite steps taken by the researcher to raise awareness of the study among
ward pharmacists, including a ‘briefing’ session prior to its commencement and posters
displayed around the pharmacy department detailing types of patients who might be
suitable.  A study ‘pack’ was also given to each pharmacist, containing background
information about the study and its eligibility criteria.  Additionally, email reminders
were sent regularly to all ward pharmacists throughout the recruitment period
In addition, this article would be improved if the author(s) could provide a short
comment on whether they believe the approach taken with involving pharmacists in the
recruitment process could have been improved, and if so, how?
The following comment has now been inserted into the discussion: Further
investigation of these barriers and possible solutions (for example, increased
pharmacist time on wards to allow for patient screening or use of information
technology to make referral easier) is ongoing.
5.On line 98, please change ‘pharmacist led’ to ‘pharmacist-led’. Done
6.On lines 81-83, the author(s) argue that patients who have carers managing their
medicines at home are ‘frailer and more susceptible to adverse drug events’; this
report would benefit from the inclusion of a reference here for this assertion,
particularly as the author(s) also use this argument again to form part of their
conclusion (line 128). If no specific reference exists to support the association, I would
suggest that this sentence is re-worded to reflect that the proposed association is a
(valid) assumption.  No specific reference exists; first two paragraphs under
subheading ‘Patient exclusions’ (lines 75-83 in original manuscript) have now been
Powered by Editor ial Manager®  and ProduXion Manager®  from  Aries System s Corporat ion
combined into a single paragraph to summarise the issue addressed (lines 91-96 in
revised manuscript)
7.On lines 116-117, please add (1.5%) after ‘only 2 patients…’ as previous findings are
presented in this way in the text (i.e. number followed by percentage in brackets).
Similarly, on line 118: ’11 patients…’, please add the percentage for information. Done
8.On lines 75-78 the author(s) state that polypharmacy is common among older adults
who have ‘managed care at home’. The relevance of this statement, in the context of
patients’ ineligibility, is not clear to this reviewer. I would ask the author(s) to review
and either remove or rephrase this point in order to clarify their intended meaning.  The
intended argument here is: the fact that patients who had carers managing their
medicines had to be excluded is a cause for concern and needs addressing in terms of
future service development.  The combination of first two paragraphs under
subheading ‘Patient exclusions’ (lines 75-83 in original manuscript) attempts to clarify
this point: In fact, patients requiring carers to manage their medication may be more in
need of a medication support service, as polypharmacy, including the use of
inappropriate medication, is common among older populations who have ‘managed
care at home’ [8].
9.In Table 1 please correct ‘Participants community pharmacy…’ to ‘Participant’s
community pharmacy…’ Done
10.Finally, I would draw the author(s) attention to the reference section of the research
report. Please review and correct the formatting of references as per the requirements
of the journal. The use of semi-colons, commas, spaces, full-stops, capital letters and
page numbering varies throughout the reference list. Also, some journals are
abbreviated and others are not. Also, in reference number 8, there is a ‘1’ after ‘Fialova
D’.  Reference list re-visited and re-formatted
Reviewer 2: Comments and Responses
Abstract:
1. In the methods section, please briefly state potential patients were visited by a
researcher to assess eligibility and discuss involvement in the trial, and reasons for
patients not participating were collected, or similar. Done
2. In the results section, please state that of the 337 potential participants, 132 were
eligible and 60 were recruited. Done
3. Suggest first two sentences of conclusion are amended to summarise most common
reasons and placed in the results section of the abstract.  Done:  following sentences
now inserted in results: Barriers to recruitment included competing priorities among
ward pharmacists, and national restrictions placed on Medicines Use Reviews, for
example housebound patients and those requiring carer support with medication.  Lack
of expected benefit resulted in a high proportion of patient refusals.
Introduction:
4. If word count allows, it may assist international readers if the description of the MUR
program was expanded. From memory the program is free for consumers - if so, this
suggest this is stated. Lines 9-13 now read: In the UK, a national service known as
Medicines Use Reviews (MUR) is offered by many community pharmacists which is
free to patients and paid for centrally by the NHS.  The MUR is a face-to-face
consultation between a patient and pharmacist, designed to identify any problems or
information needs patients have with their medicines and offer solutions [4].
5. Final sentence of introduction seems out of place (line 25) - suggest deleting or
moving. Deleted, (along with preceding sentence in order to reduce word count)
6. The section of the aim which states "to investigate the logistics of setting up the
study" could be a little more specific. Aim now reads: To identify barriers to recruitment
into a randomised controlled feasibility study of a hospital referral system to older
patients’ regular community pharmacists, and identify areas for improvement of the
service or study design.
Methods:
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7. Line 43 (Exclusion criteria) suggest restarting numbering at 1. Done
8. Can the authors please describe the process after eligibility was assessed ie did the
researcher talk to the patients, what information was provided (ie brochure) etc
The following text has been inserted (lines 44-47 of revised manuscript): The
researcher approached eligible patients to discuss involvement in the study and
provide an information leaflet.  Patients were given up to 24 hours (or longer if
requested) to consider participation.  Reasons for refusal were collected via verbal
discussion, entered into an Excel spreadsheet and categorised by the researcher.
9. Please describe the method used to collect reasons for refusal ie simple discussion
with patient or was a survey completed etc.
See response to point 8 above
Editor comments and Responses
- The results section in the abstract is not in line with the described Objective of the
study.
Objective now reads: To identify barriers to recruitment into a randomised controlled
feasibility study of a hospital referral system to older patients’ regular community
pharmacists.  Results section also amended as per reviewer 2, comment 3.
- Please insert 3-5 Statements on the impact of your findings on practice, patients or
professionals, and add them at the end of the abstract in Editorial Manager. Done
- The references to the reports need more detail, see the Vancouver style formatting
instructions.
All references checked and now in the authors’ opinion are correct
- Replace the titles of some journals by the appropriate abbreviation (ref 9 and 10).
Done
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Please accept this revised submission of a short research report: 
Post Discharge Medicines Use Review (dMUR) Service for Older Patients: Recruitment Issues in a 
Feasibility Study. 
The paper reports on the recruitment phase of a randomised controlled feasibility study of a post-
discharge medicines support service for patients aged 65 and older.  The study took place in England 
and involved referral of eligible patients from hospital to community pharmacy for post discharge 
Medicines Use Review (dMUR), a nationally commissioned service which has had low take-up in 
practice.  Participants were randomised to referral for a dMUR, or to standard discharge care. 
 
The authors feel this article sits well within the scope of the International Journal of Clinical 
Pharmacy as it describes the challenges faced by pharmacy practice researchers attempting to set up 
a controlled study of a medicines management service for one of the patient groups most vulnerable 
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Post Discharge Medicines Use Review (dMUR) Service for Older Patients: Recruitment 2 
Issues in a Feasibility Study  3 
Introduction 4 
The likelihood that an older medical patient will be discharged from hospital on the same medication 5 
they were admitted on is less than 10%, and this extensive medication regimen modification may 6 
predispose to an increased risk of mortality [1].   7 
Improved discharge information and patient education are core principles for reducing unintentional 8 
medication changes, patient harm and hospital re-admissions [2,3].  In the UK, a national service 9 
known as Medicines Use Reviews (MUR) is offered by many community pharmacists which is free to 10 
patients and paid for centrally by the NHS.  The MUR is a face-to-face consultation between a 11 
patient and pharmacist, designed to identify any problems or information needs patients have with 12 
their medicines and offer solutions [4].   13 
Since 2011, the MUR service has targeted specific patient groups, identified as being at particular 14 
risk of medication related problems or poor adherence, including patients recently discharged from 15 
hospital [4].   However, early evidence suggests uptake of post discharge MURs (dMURs) has been 16 
poor; pilot studies have shown that less than 3% of patients ͚signposted’ to the service by hospital 17 
pharmacy staff receive a dMUR [5].   18 
In 2012, a Department of Health steering group recommended that formal communication channels 19 
between hospital and community pharmacy should be established so that dMURs become an integral 20 
part of the medicines pathway [2].  However, at present, most NHS hospital Trusts do not appear to 21 
have such formalised systems in place [6].  22 
Aim 23 
Manuscript Click here to view linked References
To identify barriers to recruitment into a randomised controlled feasibility study of a hospital referral 24 
system to older patieŶts’ regular community pharmacists, and identify areas for improvement of the 25 
service or study design.   26 
Ethical Approval 27 
Ethics approval for the study was obtained from the Northwest Research Ethics Committee (Ref 28 
13/NW/0779). 29 
Method 30 
All pharmacists working on medical wards at Southport and Ormskirk NHS Trust, England were asked 31 
to identify patients over the age of 65 years who in their professional opinion might benefit from 32 
receiving a dMUR.   These patients were referred on to the researcher (HR), who visited each patient 33 
on the wards to assess eligibility.  34 
 Inclusion criteria (All must be met for eligibility) 35 
1. Taking at least one long-term medication prior to admission  36 
2. Taking five or more medicines OR one or more changes to medication during hospital stay  37 
3. PatieŶt’s ĐoŵŵuŶitǇ pharŵaĐǇ sigŶed up to reĐeiǀed referrals froŵ the hospital pharŵaĐǇ. 38 
Exclusion Criteria 39 
1. Patient will have a relative or carer managing their medication once back at home  40 
2. Patient unable to name a regular community pharmacy 41 
3. Patient unable to visit their community pharmacy for an MUR (unless community pharmacy offers 42 
telephone or domiciliary MURs). 43 
The researcher approached eligible patients to discuss involvement in the study and provide an 44 
information leaflet.  Patients were given up to 24 hours (or longer if requested) to consider 45 
participation.  Reasons for refusal were collected via verbal discussion, entered into an Excel 46 
spreadsheet and categorised by the researcher. 47 
 Consenting patients were randomised to receive a dMUR at their regular community pharmacy or 48 
standard hospital discharge care (Ŷo forŵal ĐoŵŵuŶiĐatioŶ ǁith the patieŶt’s ĐoŵŵuŶitǇ pharŵaĐǇ, 49 
unless the patient received their medication in a weekly compliance aid (monitored dosage system) 50 
in which case a discharge list of medication was faxed to the community pharmacy, usually within 24 51 
hours of discharge).   52 
 Prior to discharge each patient was told which group they had been assigned to, so they knew 53 
whether or not to expect their community pharmacist to contact them to arrange a dMUR. 54 
Results 55 
The study took place between 7th April 2014 and 6th January 2015.  Over this 9-month period 337 56 
potential participants were identified by ward pharmacists, which ultimately resulted in 60 patients 57 
recruited to the study, as shown in Figure 1.  58 
 ͚Insert Figure 1 here͛ 59 
The reasons for exclusion and refusal are displayed in Table 1. 60 
͚Insert Table 1 here͛ 61 
Discussion 62 
This study is the first to describe formalising secondary care discharge of older patients into a 63 
nationally contracted community pharmacy service (dMURs) as advocated by UK health officials and 64 
bodies representing pharmacy. 65 
Over the study period over 10,000 patients over 65 years of age were admitted to the hospital; 66 
clearly a very small proportion (3.2%) of these patients were identified by ward pharmacists and 67 
referred on to the researcher.  This highlights the pivotal role ward staff play in such studies as 68 
identified by McMurdo et al in their review of recruitment of older people to research [7].  The low 69 
referral rate was despite steps taken by the researcher to raise awareness of the study among ward 70 
pharŵaĐists, iŶĐludiŶg a ͚ďriefiŶg’ sessioŶ prior to its ĐoŵŵeŶĐeŵeŶt aŶd posters displaǇed arouŶd 71 
the pharŵaĐǇ departŵeŶt detailiŶg tǇpes of patieŶts ǁho ŵight ďe suitaďle.  A studǇ ͚paĐk’ ǁas also 72 
given to each pharmacist, containing background information about the study and its eligibility 73 
criteria.  Additionally, email reminders were sent regularly to all ward pharmacists throughout the 74 
recruitment period.  Feedback from ward pharmacists (n=7) via a focus group highlighted that 75 
identification of patients for inclusion into any type of trial was not standard practice, thus not part 76 
of their daily routine and was therefore often forgotten about.  Other barriers identified by the 77 
pharmacists were time constraints and concerns over patients’ poor health status.  Further 78 
investigation of these barriers and possible solutions (for example, increased pharmacist time on 79 
wards to allow for patient screening or use of information technology to make referral easier) is 80 
ongoing.   81 
Patient Exclusions 82 
The most frequent reason (30.8%) for ineligibility was patients’ not self-medicating at home.   This 83 
has implications for the English service specification for dMURs, which stipulates they must be 84 
conducted with the patient and not a care giver, unless the patient specifically consents for the carer 85 
to be present.  In fact, patients requiring carers to manage their medication may be more in need of 86 
a medication support service, as polypharmacy, including the use of inappropriate medication, is 87 
ĐoŵŵoŶ aŵoŶg older populatioŶs ǁho haǀe ͚ŵaŶaged Đare at hoŵe’ [8].      88 
The nature of the nationally agreed service specification for community pharmacists also accounted 89 
for a relatively high proportion of patients (n=22, 24.2% of exclusions) being excluded from the study 90 
due to being housebound and unable to attend a community pharmacy for a dMUR.  Only around 91 
one in 10 community pharmacies in this study were able to provide domiciliary visits.  Mobility 92 
issues are obviously a key consideration in this population; reduced mobility due to ill health or 93 
availability of transport has been cited by others as a challenge to the recruitment of older patients 94 
[7,9].   95 
Twenty patients (22% of exclusions), were not well enough to engage in discussion with the 96 
researcher at the time of contact, either because they were too unwell (n=9) or had cognitive 97 
impairment (n=11).  Deliriuŵ or other ĐoŶditioŶs ŵaǇ teŵporarilǇ iŵpair older patieŶts’ ĐapaĐitǇ, 98 
but they may recover by the point of discharge [7].  Therefore some patients may require more than 99 
one visit to properly engage with them regarding research.   100 
Patient Refusals 101 
Of those patients fully screened, 72 (32%) refused.  This is within the range (8-54%) found by 102 
McMurdo, and similar to a study of a pharmacist-led medication review clinic for older patients in 103 
primary care (36%) [7,10]. 104 
The key reason for non-participation was patients saw no benefit in having a dMUR with their local 105 
community pharmacist (n=20, 27.8%).  A further six patients (8.3%) stated specifically that they 106 
would rather see their GP to discuss the changes to their medication. This indicates that the concept 107 
of the dMUR was either not fully understood by these patients, or not viewed as a useful service for 108 
them.   109 
Fourteen (19.4%) patieŶts did Ŷot ǁaŶt to ďe iŶǀolǀed iŶ ’researĐh’.  Distrust of researchers and a 110 
reluctance to change their normal routine in order to take part in research have been cited 111 
elsewhere as a challenge in the recruitment of frail older patients [10].   112 
Eleven patients (15.3%) expressed concern over time commitment that the study imposed. Beyond 113 
the dMUR itself, the study included two subsequent follow-up postal questionnaires, up to 6 months 114 
after the initial discharge.  Patients may have viewed this commitment too burdensome, although 115 
comments from these patients (such as ͚I͛ve got eŶough appoiŶtŵeŶts͛) also suggested that even 116 
the initial referral for a dMUR was too onerous.  Again, an unfamiliarity with the role of the 117 
pharmacist in provision of transitioŶal Đare ŵaǇ haǀe affeĐted the perĐeiǀed ͚Đost-ďeŶefit’ of takiŶg 118 
part in this study. 119 
However, it appears that old age, per se, may not have been a barrier to participation (only 2 120 
patients (1.5%) said this was the reason for not taking part), but rather the frailty and co-morbidity 121 
that may accompany it (11 patients (15.3%) deĐliŶed due to ͚health reasoŶs’).  This is ĐoŶsisteŶt ǁith 122 
research done by others [7,10].  This potentially biases the study sample toward those patients who 123 
are ŵore ͚ǁell’ aŶd thus ŵaǇ ďe less iŶ Ŷeed of a ŵediĐatioŶ reǀieǁ.   124 
 125 
Conclusion 126 
This study has demonstrated that recruitment of older people to a study of a post discharge 127 
medicines support service provided by community pharmacists is particularly difficult for a number 128 
of reasons.  Patient unwillingness to participate, either due to ill-health or perceived lack of benefit 129 
were noted.  Additionally, pertinent to this study, the current provisions in England for post 130 
discharge MURs excluded many people from participation, including those who were possibly in 131 
greatest need. 132 
 133 
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Figure 1: Summary of Recruitment Phase of Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
337 patients referred to 
researcher 
100 discharged or transferred before 
recruitment process finished 
14 < 65 years old  
237 approached and fully 
screened by researcher 
132 eligible 
 
91 ineligible (Table 1) 
60 recruited 
 
72 refused (Table 2) 
10682 medical patients 
aged 65+ admitted  
Figure Click here to download Figure IJCP Figure One amended.docx 
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Table 1: Reasons for Ineligibility (n=91) and Refusal (n=72) 
Ineligibility Number (% of patients excluded) 
Protocol exclusions  
Patient not self-medicating at home  28 (30.8%) 
Unable to access dMUR from chosen pharmacy  22 (24.2%) 
Being discharged out of study area 11 (12.1%) 
Participant’s community pharmacy not taking 
part in the study 
2 (2.2%) 
Patient does not use a regular pharmacy  1 (1.1%) 
Patient exclusions  
Lack of capacity to consent   11 (12.1%) 
Too unwell to approach  9 (9.9%) 
MUR not needed  7 (7.7%) 
  
Reason for Refusal* Number (% of patients refusing) 
Patient sees no benefit to MUR 20 (27.8%) 
Patient already has good links with community 
pharmacy 
15 (20.8%) 
Unwilling to engage with research 14 (19.4%) 
Health reasons 11 (15.3%) 
Time constraints 11 (15.3%) 
Would rather see GP 6 (4.5%) 
Hospital counselling adequate 4 (3%) 
Patient does not want telephone MUR (home 
visit not available and patient cannot attend 
pharmacy) 
3 (2.3%) 
Patient does not agree with changes to 
medicines 
2 (1.5%) 
͞Too old͟ 2 (1.5%) 
Belief that medicines information will 
automatically be transferred to community 
pharmacy 
1 (0.8%) 
*The number of reasons for refusal is greater than the number of patients refusing, as some patients gave 
more than one reason. 
 
table Click here to download table IJCP Table One amended.docx 
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Reviewer 1: Comments and Responses 
1. In the abstract and on various other occasions throughout the manuscript, the participants 
are referred to as the ͚elderlǇ’. I ǁould adǀise that this terŵiŶologǇ ďe replaĐed ǁith ͚older adults’ or 
͚older people’, which would be regarded as more appropriate terms to use when referring to this 
population. Done 
 
2. IŶ Figure ϭ, please ĐhaŶge ͚ϭϬϲ8Ϯ MediĐal PatieŶts’ to ͚ϭϬϲ8Ϯ ŵediĐal patieŶts’ aŶd ͚ϯ37 
PatieŶts’ to ͚ϯϯϳ patieŶts’, ;loǁerĐase), in keeping with the word formatting in the other boxes 
within the same figure. Done 
 
3. LiŶe ϲ8: ͚FeedďaĐk froŵ ǁard pharŵaĐists ǀia a foĐus group…’ I would advise that you add 
(n=x) or similar, to indicate how many ward pharmacists provided feedback in the focus group. Done 
(n=7) 
 
4. Whilst this article predominantly focusses on recruitment being problematic due to it being 
a study attempting to recruit older adults, an important finding described in this research report was 
that, overall, the pharmacists only referred 3.2% of all patients admitted, which is a significantly 
lower proportion than one would expect given the wider patient population admitted to hospitals. 
As such, this clearly represented a major barrier to the recruitment process. As the author(s) states 
that recruitment of partiĐipaŶts to the studǇ ǁas ͚ofteŶ forgotteŶ aďout’ by ward pharmacists (line 
70), it is perhaps unclear to the reader what steps (if any) were taken to ensure that pharmacists 
were aware of their role in the recruitment process. This point is also pertinent as the author(s) also 
report that of the 337 patients referred to the researcher by the pharmacists, 105 were ineligible for 
inclusion as they did not meet the specified study inclusion criteria. As this represents nearly one 
third of all those who were referred, this would lead this reviewer to assume that the ward 
Response to reviewer's comments
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Patients: Recruitment Issues in a Feasibility Study 
30/10/15 
 
pharmacists involved in recruitment were not aware of the studǇ’s inclusion/exclusion criteria (as 
suggested in lines 35-36). To address this issue, I think this article would benefit from a comment in 
the discussion section to clarify exactly how and to what extent the pharmacists involved in the 
recruitment were informed of the recruitment process.  
The following comment has now been inserted into the discussion: The low referral rate was despite 
steps taken by the researcher to raise awareness of the study among ward pharmacists, including a 
͚ďriefiŶg͛ sessioŶ prior to its ĐoŵŵeŶĐeŵeŶt aŶd posters displaǇed arouŶd the pharŵaĐǇ departŵeŶt 
detailing types of patieŶts ǁho ŵight ďe suitaďle.  A studǇ ͚paĐk͛ ǁas also giveŶ to eaĐh pharŵaĐist, 
containing background information about the study and its eligibility criteria.  Additionally, email 
reminders were sent regularly to all ward pharmacists throughout the recruitment period  
In addition, this article would be improved if the author(s) could provide a short comment on 
whether they believe the approach taken with involving pharmacists in the recruitment process 
could have been improved, and if so, how? 
The following comment has now been inserted into the discussion: Further investigation of these 
barriers and possible solutions (for example, increased pharmacist time on wards to allow for patient 
screening or use of information technology to make referral easier) is ongoing. 
 
5. OŶ liŶe ϵ8, please ĐhaŶge ͚pharŵaĐist led’ to ͚pharŵaĐist-led’. Done 
 
6. On lines 81-83, the author(s) argue that patients who have carers managing their medicines 
at home are ͚frailer aŶd ŵore susĐeptiďle to adverse drug eveŶts͛; this report would benefit from the 
inclusion of a reference here for this assertion, particularly as the author(s) also use this argument 
again to form part of their conclusion (line 128). If no specific reference exists to support the 
association, I would suggest that this sentence is re-worded to reflect that the proposed association 
is a (valid) assumption.  No speĐifiĐ refereŶĐe eǆists; first tǁo paragraphs uŶder suďheadiŶg ͚Patient 
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eǆĐlusioŶs͛ (lines 75-83 in original manuscript) have now been combined into a single paragraph to 
summarise the issue addressed (lines 91-96 in revised manuscript)  
 
7. On lines 116-117, please add (1.5%) after ͚oŶlǇ Ϯ patieŶts…͛ as previous findings are 
presented in this way in the text (i.e. number followed by percentage in brackets). Similarly, on line 
118: ͛ϭϭ patieŶts…͛, please add the percentage for information. Done 
 
8. On lines 75-78 the author(s) state that polypharmacy is common among older adults who 
have ͚ŵaŶaged Đare at hoŵe͛. The relevance of this statement, in the context of patieŶts’ 
ineligibility, is not clear to this reviewer. I would ask the author(s) to review and either remove or 
rephrase this point in order to clarify their intended meaning.  The intended argument here is: the 
fact that patients who had carers managing their medicines had to be excluded is a cause for 
concern and needs addressing in terms of future service development.  The combination of first two 
paragraphs uŶder suďheadiŶg ͚PatieŶt eǆĐlusioŶs͛ (lines 75-83 in original manuscript) attempts to 
clarify this point: In fact, patients requiring carers to manage their medication may be more in need 
of a medication support service, as polypharmacy, including the use of inappropriate medication, is 
common among older populatioŶs ǁho have ͚ŵaŶaged Đare at hoŵe͛ [8].      
 
9. IŶ Taďle ϭ please ĐorreĐt ͚PartiĐipaŶts ĐoŵŵuŶitǇ pharŵaĐǇ…’ to ͚PartiĐipaŶt’s ĐoŵŵuŶitǇ 
pharŵaĐǇ…’ Done 
 
10. Finally, I would draw the author(s) attention to the reference section of the research report. 
Please review and correct the formatting of references as per the requirements of the journal. The 
use of semi-colons, commas, spaces, full-stops, capital letters and page numbering varies throughout 
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the reference list. Also, some journals are abbreviated and others are not. Also, in reference number 
8, there is a ͚ϭ’ after ͚Fialoǀa D’.  Reference list re-visited and re-formatted 
 
Reviewer 2: Comments and Responses 
Abstract: 
1. In the methods section, please briefly state potential patients were visited by a researcher to 
assess eligibility and discuss involvement in the trial, and reasons for patients not participating were 
collected, or similar. Done 
2. In the results section, please state that of the 337 potential participants, 132 were eligible and 60 
were recruited. Done 
3. Suggest first two sentences of conclusion are amended to summarise most common reasons and 
placed in the results section of the abstract.  Done:  following sentences now inserted in results: 
Barriers to recruitment included competing priorities among ward pharmacists, and national 
restrictions placed on Medicines Use Reviews, for example housebound patients and those requiring 
carer support with medication.  Lack of expected benefit resulted in a high proportion of patient 
refusals. 
 
Introduction: 
4. If word count allows, it may assist international readers if the description of the MUR program 
was expanded. From memory the program is free for consumers - if so, this suggest this is stated. 
Lines 9-13 now read: In the UK, a national service known as Medicines Use Reviews (MUR) is offered 
by many community pharmacists which is free to patients and paid for centrally by the NHS.  The 
MUR is a face-to-face consultation between a patient and pharmacist, designed to identify any 
problems or information needs patients have with their medicines and offer solutions [4].   
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5. Final sentence of introduction seems out of place (line 25) - suggest deleting or moving. Deleted, 
(along with preceding sentence in order to reduce word count)  
 
6. The section of the aim which states "to investigate the logistics of setting up the study" could be a 
little more specific. Aim now reads: To identify barriers to recruitment into a randomised controlled 
feasibility study of a hospital referral sǇsteŵ to older patieŶts͛ regular ĐoŵŵuŶitǇ pharŵaĐists, aŶd 
identify areas for improvement of the service or study design. 
 
Methods: 
7. Line 43 (Exclusion criteria) suggest restarting numbering at 1. Done 
 
8. Can the authors please describe the process after eligibility was assessed ie did the researcher talk 
to the patients, what information was provided (ie brochure) etc  
The following text has been inserted (lines 44-47 of revised manuscript): The researcher approached 
eligible patients to discuss involvement in the study and provide an information leaflet.  Patients were 
given up to 24 hours (or longer if requested) to consider participation.  Reasons for refusal were 
collected via verbal discussion, entered into an Excel spreadsheet and categorised by the researcher. 
 
9. Please describe the method used to collect reasons for refusal ie simple discussion with patient or 
was a survey completed etc. 
See response to point 8 above 
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Editor comments and Responses 
- The results section in the abstract is not in line with the described Objective of the study. 
Objective now reads: To identify barriers to recruitment into a randomised controlled feasibility study 
of a hospital referral sǇsteŵ to older patieŶts͛ regular ĐoŵŵuŶitǇ pharŵaĐists.  Results section also 
amended as per reviewer 2, comment 3. 
 
- Please insert 3-5 Statements on the impact of your findings on practice, patients or professionals, 
and add them at the end of the abstract in Editorial Manager. Done 
 
- The references to the reports need more detail, see the Vancouver style formatting instructions.  
All references checked and now in the authors’ opinion are correct 
- Replace the titles of some journals by the appropriate abbreviation (ref 9 and 10). Done 
 
 
